Amakuru rusange
Pepsinogen ni pro-form ya pepsin kandi ikorerwa mu gifu na selile nkuru.Igice kinini cya pepsinogene gisohoka mu gifu cya gastric ariko umubare muto urashobora kuboneka mumaraso.Impinduka ziterwa na serumu pepsinogen zagaragaye hamwe n'indwara ya Helicobacter pylori (H. Pylori), indwara y'ibisebe bya peptike, gastrite, na kanseri yo mu gifu.Isesengura ryuzuye rishobora kugerwaho mugupima igipimo cya pepsinogen I / II.
Icyifuzo | CLIA (Gufata-Kumenya): 3A7-13 ~ 2D4-4 |
Isuku | > 95%, bigenwa na SDS-PAGE |
Buffer | 20 mM PB, 150 mM NaCl, 0.1% Proclin 300, pH7.4 |
Ububiko | Ubike mubihe bidasanzwe kuri -20 ℃ kugeza -80 ℃ umaze kwakira. Saba kugabanya poroteyine muke kugirango ubike neza. |
izina RY'IGICURUZWA | Injangwe.Oya | Indangamuntu ya Clone |
PGII | AB0006-1 | 3A7-13 |
AB0006-2 | 2C2-4-1 | |
AB0006-3 | 2D4-4 |
Icyitonderwa: Bioantibody irashobora kugereranya ingano kubyo ukeneye.
1.Kodoi A, Haruma K, Yoshihara M, n'abandi.[Ubushakashatsi bwakozwe kuri pepsinogen ya I na II butanga kanseri yo mu gifu]. [J]Nihon Shokakibyo Gakkai zasshi = Ikinyamakuru cyo mu Buyapani cya gastro-enterologiya, 1993, 90 (12): 2971.
2.Xiao-Mei L, Xiu Z, Ai-Min Z.Ubushakashatsi bwa Clinical of serum pepsinogen kugirango hamenyekane kanseri yo mu gifu n'ibisebe byo mu nda [J].Indyo igezweho & Intervention, 2017.